Literature DB >> 2503923

Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.

J Thiele1, B Hoeppner, R Zankovich, R Fischer.   

Abstract

Histomorphometry was performed on representative trephine biopsies of the bone marrow on admission of 50 patients (21 male, 29 female - age 67 years) with so-called primary osteomyelofibrosis/-sclerosis (OMF) not preceded by any other subtype of chronic myeloproliferative disorders. This study was firstly aimed at testing correlations between histological features (amount of haematopoiesis, cytological aspects of megakaryocytes, density of reticulin and collagen fibres and degree of osteosclerosis) and laboratory data, as well as spleen size and duration of relevant prediagnostic symptoms. Secondly, we concentrated on a discrimination of OMF patients into two subgroups according to bone marrow morphology and clinical variables. Statistical evaluation of histomorphometric variables and haematological findings disclosed that there was a progressive fibro-osteosclerotic process in the evolution of disease features. Increase in medullary fibrosis was significantly paralleled by an abnormal or pleomorphic megakaryopoiesis in the bone marrow: there was an increase in irregularity of perimeters for megakaryocytes and naked nuclei combined with smaller sizes of these elements including the nuclei. Additionally, there was a greater number of pycnotic bare nuclei. A number of morphometric features (density of fibres, degree of osteosclerosis, amount of haematopoiesis) were associated with corresponding clinical data (spleen size, length of preclinical history). By consideration of a set of basic histomorphometric variables our cohort of 50 patients could be divided into an early hyperplastic subtype with no or minimal medullary reticulin and another group with conspicuous fibrotic and osteosclerotic alterations of the bone marrow. It was noticeable that we found no significant correlation between amount of haematopoiesis or marrow cellularity with splenomegaly. This result suggests that splenic haematopoiesis (myeloid metaplasia) may represent an autonomous or neoplastic process and not only compensation for a failing fibro-osteosclerotic bone marrow.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503923     DOI: 10.1007/bf00724905

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  46 in total

Review 1.  Patho-anatomical features of the bone marrow.

Authors:  K Lennert; K Nagai; E W Schwarze
Journal:  Clin Haematol       Date:  1975-06

2.  Bone marrow fibre production in myelofibrosis: a quantitative study.

Authors:  S A Bentley; C J Herman
Journal:  Br J Haematol       Date:  1979-05       Impact factor: 6.998

3.  [Myelofibrosis during hematologic diseases. Apropos of 402 cases].

Authors:  C Devred; J Diebold
Journal:  Sem Hop       Date:  1974-05-20

4.  Platelet alpha granules contain a growth factor for fibroblasts.

Authors:  D R Kaplan; F C Chao; C D Stiles; H N Antoniades; C D Scher
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

5.  Bone marrow biopsy with unaltered architecture: a new biopsy device.

Authors:  K Jamshidi; W R Swaim
Journal:  J Lab Clin Med       Date:  1971-02

Review 6.  Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.

Authors:  J Laszlo
Journal:  Semin Hematol       Date:  1975-10       Impact factor: 3.851

7.  Immunologic abnormalities in myelofibrosis with activation of the complement system.

Authors:  B R Gordon; M Coleman; P Kohen; N K Day
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

8.  Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.

Authors:  J Thiele; K G Simon; R Fischer; R Zankovich
Journal:  Pathol Res Pract       Date:  1988-08       Impact factor: 3.250

9.  Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.

Authors:  M Lazzarino; E Morra; A Castello; D Inverardi; A Coci; G Pagnucco; U Magrini; G Zei; C Bernasconi
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

Review 10.  Chronic myeloproliferative disorders (CMPD).

Authors:  R Burkhardt; R Bartl; K Jäger; B Frisch; G Kettner; G Mahl; M Sund
Journal:  Pathol Res Pract       Date:  1984-11       Impact factor: 3.250

View more
  7 in total

1.  The spleen in osteomyelofibrosis. A morphological and immunohistochemical study of 30 cases.

Authors:  S Falk; D Mix; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts.

Authors:  T Buhr; A Georgii; O Schuppan; A Amor; V Kaloutsi
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 3.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities.

Authors:  V Kaloutsi; R S Fritsch; T Buhr; I Restrepo-Specht; W Widjaja; A Georgii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis.

Authors:  Cesar Cilento Ponce; Maria de Lourdes F Chauffaille; Silvia Saiuli M Ihara; Maria Regina R Silva
Journal:  Med Oncol       Date:  2011-12-27       Impact factor: 3.064

6.  Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.

Authors:  J Thiele; C Braeckel; S Wagner; B Falini; D Dienemann; H Stein; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Validation of marrow fat assessment using noninvasive imaging with histologic examination of human bone samples.

Authors:  Luke Arentsen; Masashi Yagi; Yutaka Takahashi; Patrick J Bolan; Melissa White; Douglas Yee; Susanta Hui
Journal:  Bone       Date:  2014-11-12       Impact factor: 4.398

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.